Details for Patent: 7,465,462

✉ Email this page to a colleague

Summary for Patent: 7,465,462

Title:	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
Abstract:	A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a pharmaceutically acceptable salt thereof, which are coated with a rate-controlling polymer that allows controlled release of the SSRI over a period of not less than about 12 hours after oral administration. The rate controlling polymer includes a film-forming water-insoluble polymer, or a mixture of a film-forming water-insoluble polymer and a film-forming water-soluble polymer.
Inventor(s):	Jeary; Theresa Ann (Roscommon, IE), Morrissey; Catherine Ann (County Westmeath, IE), Stark; Paul (County Westmeath, IE)
Assignee:	Elan Pharma International Limited (Monksland Athlone County Westmeath, IL)
Application Number:	09/744,169
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form; Device; Use;

Drugs Protected by US Patent 7,465,462

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,465,462

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Ireland	990406	May 20, 1999

PCT Information
PCT Filed	May 10, 2000	PCT Application Number:	PCT/IE00/00060
PCT Publication Date:	November 30, 2000	PCT Publication Number:	WO00/71099

International Family Members for US Patent 7,465,462

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	367153	⤷ Sign Up
Australia	4426700	⤷ Sign Up
Australia	782059	⤷ Sign Up
Canada	2374039	⤷ Sign Up
Canada	2698347	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.